Instrument Inactif

Communiqués Telferscot Resources Inc Canadian Securities Exchange

Actions

Cours en clôture Canadian Securities Exchange Autres places de cotation
-	-

2023	Canntab Therapeutics Limited fait le point sur la livraison de ses produits	CI
2023	Canntab Therapeutics Limited annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 28 février 2023	CI

Canadian Investment Regulatory Organization Trading Halt - PILL	05/10/23	AQ
Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order	18/09/23	NE
CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO	22/08/23	AQ
IIROC Trade Resumption - PILL	22/11/22	AQ
IIROC Trading Halt - PILL	21/11/22	AQ
CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO	23/08/22	AQ
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET	22/08/22	AQ
CANNTAB ANNOUNCES CHANGE OF AUDITOR	30/05/22	AQ
Canntab Therapeutics : 2022Feb28 Q3 Interim MD&A	30/04/22	PU
Canntab Therapeutics : 2022Feb28 q3 Interim FS	30/04/22	PU
Canntab Engages Hamish Sutherland as Strategic Advisor	13/04/22	AQ
CANNTAB ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE PRIVATE PLACEMENT, WARRANT EXPIRY EXTENSION AND CORPORATE UPDATE	02/02/22	AQ
Canntab Therapeutics : 2021Nov30 Q2 MD&A	01/02/22	PU
Canntab Therapeutics : 2021Nov30 Q2 Interim FS	01/02/22	PU
Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids	10/01/22	AQ
Canntab Announces Agreement with Pathway Health	02/12/21	AQ
IIROC Trade Resumption - PILL	11/11/21	AQ
IIROC Trading Halt - PILL	10/11/21	AQ
Canntab Therapeutics : Announces the Early Exercise of $1,259,250 Warrants	03/06/21	AQ
Canntab Therapeutics : Mourns the Loss of Co-Founder	25/05/21	AQ

Aucun résultat pour cette recherche